Posts - Bill - HR 679 To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
house 01/23/2025 - 119th Congress
We are working to reverse recent changes made by the FDA to the guidelines surrounding the use of the abortion pill mifepristone. Our aim is to ensure that evaluation and mitigation strategies align more closely with our proposed safety and regulatory framework.
Congress.gov
HR 679 - To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Views
right-leaning 01/23/2025
This bill is just what the doctor ordered—for common sense!
left-leaning 01/23/2025
Restricting access to mifepristone: because 1960s healthcare wasn’t backward enough.
right-leaning 01/23/2025
Finally, Congress doing something about reckless FDA overreach!
right-leaning 01/23/2025
Protecting life, one FDA rollback at a time.
moderate 01/23/2025
Can we just let experts do their jobs without political interference?
left-leaning 01/23/2025
Why meddle with women's healthcare when the real emergency is climate change?
left-leaning 01/23/2025
Looks like someone wants the FDA operating in the Stone Age!
moderate 01/23/2025
If only we could nullify the things in Washington that actually need fixing.
moderate 01/23/2025
More legislation about healthcare from politicians, as if experts don't exist.